Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes

Authors

Jace P. Landry, LSU Health Sciences Center - New OrleansFollow
Yvette Mattison, LSU Health Sciences Center - New OrleansFollow
Denise Danos, LSU Health Sciences Center - New OrleansFollow
Philip Boudreaux, LSU Health Sciences Center - New OrleansFollow
Ramcharan Thiagarajan, LSU Health Sciences Center - New OrleansFollow
Mary Maluccio, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

3-6-2023

Publication Title

Annals of Surgical Oncology

Abstract

Society of Surgical Oncology SSO 2023 - International Conference on Surgical Cancer Care, Boston, MA March 22 - 25, 2023

First Page

S18

Volume

30

Comments

Abstract Number: 30

Recommended Citation

Landry, Jace P.; Mattison, Yvette; Danos, Denise; Boudreaux, Philip; Thiagarajan, Ramcharan; and Maluccio, Mary, "Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes" (2023). School of Medicine Faculty Publications. 2684.
https://digitalscholar.lsuhsc.edu/som_facpubs/2684
10.1245/s10434-023-13332-7